November 05, 2021

The Master Class XXII • 2021

Disclaimer

The recommendations provided from the authors were obtained on November 5, 2021. The opinions and recommendations do not necessarily accurately reflect the current state of affairs or the current advice the authors may choose to provide in the same circumstances. Please refer to the current guidelines or the Canadian Association of Gastroenterology (CAG) for up-to-date treatment options.

Learning Objectives

The educational objective of the Mentoring in IBD XXII program is to increase awareness of current developments and best practices in inflammatory bowel disease (IBD) management, promote collaboration among Canadian gastroenterologists, and optimize treatment of IBD.

Participants in this program will be able to:

  • Discuss major changes to vaccination guidelines and the impact on IBD patients and practice
  • Explore dysplasia surveillance techniques in IBD
  • Examine sequencing of therapies with new molecules and combination biologics

Vaccination Guidelines Update

Presented by Jennifer Jones, MD

Abstract

Plenary Presentation

PLP Template (Fillable)

Dysplasia Surveillance in IBD

Presented by Talat Besssissow, MD

Workshop Case Study

Abstract

Plenary Presentation

PLP Template (Fillable)

Advanced Therapies in IBD: Mix & Match?

Presented by Vipul Jairath, MD

Workshop Case Study

Abstract

Plenary Presentation

PLP Template (Fillable)